China NT Pharma Group Co., Ltd.
| Hong Kong Stock Exchange: 1011
China NT Pharma Group Co. Ltd. engages in manufacturing, sale and distribution of pharmaceutical and vaccine products. The company also engages in the provision of marketing and promotion services to suppliers in China. It focuses on promoting and distributing third-party and self-produced proprietary pharmaceutical products. The company operates its business through three business segments: Third-Party Pharmaceutical Promotion and Sales, Proprietary Products Production and Sales, and Third-Party Vaccines and Other Pharmaceuticals. The Third-Party Pharmaceutical Promotion and Sales segment engages in the pharmaceutical promotion and sales derives turnover from selling and marketing third-party manufactured pharmaceutical products to customers and providing marketing and promotion services. The Proprietary Products Production and Sales segment focuses on its branded products production and sales derives turnover from production and sales of NT branded products and generic drugs through Suzhou First Pharmaceutical Co. Ltd., a wholly-owned subsidiary The Third-Party Vaccines and Other Pharmaceuticals segment includes sales from vaccine promotion, vaccine supply chain and pharmaceutical supply chain. China NT Pharma Group was founded by David Ng in 1995 and is headquartered in Hong Kong.